MedPacto, Inc.
Develops biomarker-based precision therapies for oncology and other incurable diseases.
235980 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 명달로 92, 보림빌딩, 서초구
- Website:
- http://www.medpacto.com/eng/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of innovative, biomarker-based therapeutics. Utilizing a genome-based drug discovery platform, the company aims to deliver precision medicine and personalized therapies. Its research and development pipeline focuses on creating first-in-class treatments for incurable diseases, with core areas in oncology, autoimmune disorders, metabolic diseases, and bone and joint diseases. A key scientific strategy includes modulating the tumor microenvironment to enhance the efficacy of anticancer drugs. The company is committed to transforming novel targets into therapeutic solutions for patients with unmet medical needs.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for MedPacto, Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all MedPacto, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for MedPacto, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
